Results 221 to 230 of about 443,078 (244)

The burden of diabetic foot ulcers in a multi‐ethnic Asian cohort

open access: yesDiabetic Medicine, Volume 43, Issue 10, October 2026.
Abstract Aims Diabetic foot ulcers (DFUs) are a major source of morbidity among individuals with diabetes mellitus (DM), imposing a substantial burden on healthcare systems. Our institution established a multidisciplinary service aiming to facilitate early specialist intervention for DFU management.
Zongwen Wee   +2 more
wiley   +1 more source

Clinical and Economic Burden of Obesity and Cardiovascular Disease Among Medicare Fee‐For‐Service Beneficiaries

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9155-9165, October 2026.
ABSTRACT Aims This retrospective cohort study described clinical outcomes, healthcare resource utilisation (HCRU), and costs among Medicare beneficiaries with or without obesity and stratified by cardiovascular disease (CVD) risk. Materials and Methods Using Medicare FFS claims (Jan 2016–Dec 2022), beneficiaries were indexed after 12 months of ...
Jiayin Xue   +9 more
wiley   +1 more source

Longitudinal Left Atrial Remodeling With Pharmacological Rhythm Versus Rate Control in Paroxysmal and Persistent Atrial Fibrillation

open access: yesEchocardiography, Volume 43, Issue 10, October 2026.
Among patients with paroxysmal or persistent atrial fibrillation, pharmacological rhythm control was associated with more favorable longitudinal left atrial remodeling than rate control. LAVI increased during rate control but remained stable during rhythm control, with an adjusted 9.38 mL/m2 lower follow‐up LAVI. The association was also observed among
Shao‐Fu Chien   +4 more
wiley   +1 more source

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 787-798, October 2026.
ABSTRACT Acute Myeloid Leukemia predominantly affects older adults, who often present with comorbidities, functional impairment, and frailty, limiting eligibility for intensive chemotherapy or allogeneic transplantation. Historically, treatment options were restricted to hypomethylating agents, low‐dose cytarabine, hydroxyurea, or supportive care, with
Antonella Bruzzese   +11 more
wiley   +1 more source

Wearable Electronic Monitoring of Vital Signs in Hospitalised Adults: A Nursing Focused Scoping Review of Clinical, Economic and Implementation Outcomes

open access: yesJournal of Advanced Nursing, Volume 82, Issue 10, Page 9061-9111, October 2026.
ABSTRACT Aim To synthesise evidence on wearable devices for continuous vital signs monitoring in adult hospital inpatients, focusing on clinical effectiveness, nursing perspectives, workflow impact, patient experience and resource implications. Design Scoping review.
Sian Myfanwy Shaw   +2 more
wiley   +1 more source

SURPASS‐CVOT and the Emerging Biology of Cardiometabolic Benefit

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 8753-8756, October 2026.
Salvatore Corrao   +2 more
wiley   +1 more source

2018 ESC/EACTS Guidelines on myocardial revascularization [PDF]

open access: yesEuropean Heart Journal, 2019
The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS).
Robert A Byrne, Philippe Kolh
exaly   +4 more sources

Complete Revascularization with Multivessel PCI for Myocardial Infarction [PDF]

open access: yesNew England Journal of Medicine, 2019
BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction. Whether PCI of nonculprit lesions further
Josep Rodés-Cabau, Alvaro Avezum
exaly   +2 more sources

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction

New England Journal of Medicine, 2023
Thomas Münzel   +2 more
exaly  

Home - About - Disclaimer - Privacy